ACM
NPTN

Advent Capital Management’s NEOPHOTONICS CORP NPTN Stock Holding History

Advent Capital Management’s Portfolio NPTN Stock Details NPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-40,000
Closed -$252K – 237
2019
Q1 		$252K Buy
+40,000
New +$280K 0.01% 179

Other funds holding NPTN

Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

Advent Capital Management's NPTN Position: Q2 2019 in Review

Advent Capital Management sold out of NEOPHOTONICS CORP (NPTN) in Q2 2019, closing a stake of 40,000 shares — an estimated $252K sold.

Advent Capital Management first reported a position in NPTN in Q1 2019 and held it in 1 quarter. The position peaked at $252K in Q1 2019. 113 funds tracked by Wall St. Rank hold NPTN as of Q2 2019.

  • Advent Capital Management reported no remaining NEOPHOTONICS CORP position as of Q2 2019 after selling out during the quarter.
  • Advent Capital Management sold 40,000 NEOPHOTONICS CORP shares in Q2 2019, an estimated $252K.
  • Advent Capital Management first reported a position in NEOPHOTONICS CORP in Q1 2019 and held it in 1 quarter.
  • Advent Capital Management's NEOPHOTONICS CORP position peaked at $252K in Q1 2019.
  • 113 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q2 2019.

Based on Advent Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.